Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow transplantation for thalassaemia

G Lucarelli1

  • 1Divisione Ematologica, Ospedale di Pesaro, Italy.

Journal of Internal Medicine. Supplement
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery.

European urology open science·2022
Same author

Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor.

World journal of urology·2019
Same author

Bone Marrow Transplantation in Thalassemia.

Turkish journal of haematology : official journal of Turkish Society of Haematology·2016
Same author

HLA-A-B-C-DRB1-DQB1 phased haplotypes in 124 Nigerian families indicate extreme HLA diversity and low linkage disequilibrium in Central-West Africa.

Tissue antigens·2015
Same author

Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Hematopoietic SCT for the Black African and non-Black African variants of sickle cell anemia.

Bone marrow transplantation·2014

Bone marrow transplantation offers radical treatment for thalassemia patients with an HLA-identical donor. Survival rates vary by patient class and conditioning regimen, with Class 1 and 2 showing higher success than Class 3.

Area of Science:

  • Hematology
  • Immunology
  • Pediatric Oncology

Background:

  • Bone marrow transplantation (BMT) is a potentially curative treatment for thalassemia.
  • Patient stratification and conditioning regimens significantly impact BMT outcomes.
  • Human Leukocyte Antigen (HLA)-identical sibling donors are crucial for successful allogeneic BMT.

Purpose of the Study:

  • To evaluate the efficacy of two distinct BMT conditioning protocols based on patient class.
  • To compare survival and event-free survival rates across different patient classes and age groups.
  • To establish the role of HLA-identical BMT in the radical treatment of thalassemia.

Main Methods:

  • Retrospective analysis of 116 Class 1, 271 Class 2, 125 Class 3, and 108 adult patients undergoing HLA-identical BMT.

Related Experiment Videos

  • Patients were assigned to protocols based on pre-transplant class, independent of age.
  • Conditioning regimens included varying doses of busulfan, cyclophosphamide, cyclosporine, and methotrexate.

    • Main Results:

    • Class 1 patients: 95% survival, 90% event-free survival.
    • Class 2 patients: 85% survival, 81% event-free survival.
    • Class 3 patients: 78% survival, 54% event-free survival.
    • Adult patients (17-35 years) in Class 2/3 protocols: 67% survival, 63% event-free survival.

    Conclusions:

    • HLA-identical BMT is the sole radical treatment for thalassemia.
    • Conditioning regimen intensity influences BMT outcomes, with higher success in Class 1 and 2.
    • Further optimization of protocols for Class 3 and adult patients is warranted.